RNA, U6 small nuclear 511, pseudogene (RNU6-511P)

RNU6-511P is a *pseudogene*, meaning it is a genomic sequence resembling the U6 small nuclear RNA gene (an essential component of the spliceosome) but often lacks the ability to produce a functional transcript or protein[6]. The canonical U6 snRNA plays a key role in pre-mRNA splicing, acting within the spliceosome to facilitate intron removal[1][3][5]. Unlike its parent gene, RNU6-511P does not encode a functional molecule and is not a recognized therapeutic target nor a receptor, enzyme, transporter, or transcription factor. Pseudogenes related to snRNAs can sometimes be transcribed or participate in RNA-based regulatory networks, but there is no evidence that RNU6-511P itself has such functions or disease associations. This entry is not a proper target suitable for drug development or biomarker use[6]. Additional notes: - RNU6-511P is *not* a protein, enzyme, receptor, or other typical drug target. - It is considered a processed pseudogene because it arose via retrotransposition rather than by standard gene duplication and mutation[1]. - There is no evidence that this specific pseudogene contributes to disease, interacts with drugs, or acts as a biomarker or regulator. - The entry is somewhat incorrect in the context of drug target databases. If a functional U6 snRNA were sought, it should not be this pseudogene but the canonical U6 snRNA.

Other names

RNU6-511PRNA, U6 small nuclear 511, pseudogene